Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) - Lee, MM Y; Brooksbank, KJ M; Wetherall, K (Circulation, 2021)
et al.